
Zhang and colleagues report autoantibodies neutralizing interferon-α, -ω, and -β in a man who died from H7N7 influenza and mutations in the viral proteins that may facilitate adaptation to humans. Read the full report: nej.md/4iJ84CN

Respiratory @NHSTayside | Hon Sen Lect @dundeeuni | Complex Lung Infections | Co-Chair Scottish TB Network | Own opinions

Zhang and colleagues report autoantibodies neutralizing interferon-α, -ω, and -β in a man who died from H7N7 influenza and mutations in the viral proteins that may facilitate adaptation to humans. Read the full report: nej.md/4iJ84CN

【The Spectrum of Tuberculosis from Infection to Disease】 @HeartlandNTBC & @MayoClinicINFD 👉Really useful resource for all clinicians (PDF available online for FREE)! 👉heartlandntbc.org/wp-content… #TBIntensive #IDFellow #IDMedEd

The 2022 Lancet COPD Commission called for a shift in thinking about COPD from an end-stage disease to one with different types of risk factors and trajectories. A new update reviews progress made in the take-up of the recommendations: spkl.io/60107wF4I

The new @TheLancet commission on COPD is now available here sciencedirect.com/science/ar…

Multiple autoimmune labels. Could one immune defect connect them? High-yield pearls from #ACR26: WHEN TO SUSPECT Early onset • multiorgan autoimmunity • refractory disease • enteropathy • lymphoproliferation • recurrent infections. ADULTS COUNT ~25% of IEI patients first develop symptoms in adulthood. Autoimmunity may be the only clue; absent infections or family history does not exclude IEI. RECOGNISE THE PATTERN → RECONSIDER THE DIAGNOSIS • Sicca/nephritis + infections → APDS • Autoimmunity + cytopenias/enteropathy → CTLA4/LRBA • Arthritis + ILD/alveolar haemorrhage → COPA • Behçet-like disease → HA20 or STAT1 GOF GENETICS CAN REDIRECT THERAPY APDS → leniolisib CTLA4/LRBA → abatacept STAT1 GOF → consider JAK inhibition TEST BEYOND SMALL PANELS Consider exome/genome + copy-number analysis; reanalyse negative results. Suspected somatic variants need adequate sequencing depth. The next breakthrough may be a molecular diagnosis. Credit: Prof Megan A. Cooper #ACR26 #ACRambassador #Rheumatology #ClinicalImmunology #PrecisionMedicine

Original Article: Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (phase 3 TRIUMPH-1 trial) nej.md/4ycgSHz Editorial: A Triple Incretin Agonist for Obesity, Osteoarthritis, and Sleep Apnea nej.md/4izSuJs #Endocrinology #Rheumatology

In two replicate phase 3 trials involving patients with COPD who were receiving inhaled maintenance therapy, add-on tozorakimab resulted in a lower rate of moderate or severe exacerbations than placebo. Full results of the OBERON and TITANIA trials and Research Summary: nej.md/4zNqtWJ

Terrific series of comments arguing against the use of RIF in MAC pulmonary disease. Thank you, @adil_rashidk
Several lines of evidence make a stong case *aganist* using Rif in MAC-PD: 1) Rif MICs aganist M avium remain far above current breakpoints for S aureus /MTB (0.06/0.5 mg/L); Median MIC being around 4 mg/L .....(1/n)

🧫🟢 ¿Por qué un hongo puede ser "susceptible" en el laboratorio 🔬, pero el paciente no mejora? 🏥🤔 📖 The Lancet Infectious Diseases explica por qué la concentración mínima inhibitoria (CMI) no predice por sí sola la respuesta clínica. #Micología #Antifúngicos 🍄🧬 La respuesta depende de múltiples factores: 🔬 Especie fúngica 💊 Exposición al antifúngico 📍 Foco de infección 🦠 Biopelículas y persistencia 🛡️ Inmunidad del paciente 📊 Los autores proponen un algoritmo para investigar las discrepancias entre laboratorio y evolución clínica. 🩺🔍 ¿Qué hacer? ✅ Integrar datos clínicos y farmacocinéticos. 💊 Monitorizar el antifúngico cuando esté indicado. 🎯 Controlar el foco infeccioso. 💡 👇🏻 doi.org/10.1016/S1473-3099(2… #Microbiología #InfeccionesFúngicas @SEMicrobiologia

📢Happy to share an editorial, just published in @ThoraxBMJ, on a post hoc analysis of the CLEAR trial (PMID: 42557060)! To test or not to test: reassessing the need for drug response assessment before inhaled hypertonic saline thorax.bmj.com/content/early…

New #IDSAGuidelines! IDSA has released updated evidence-based recommendations on the prevention of invasive aspergillosis in adult solid organ transplant recipients: bit.ly/4whe7Dx

🆕💥ENCORE RCT A Phase 3b, Double-blind, RCT Amikacin Liposome Inhalation Suspension ( ALIS) In Newly Diagnosed Mycobacterium avium Complex Lung Disease #IDXposts academic.oup.com/ajrccm/adva…

ERJ Open Research: Treatment of patients with bronchiectasis with hypertonic saline or carbocisteine does not significantly reduce sputum viscoelastic properties and biomarker levels or alter bacterial community composition bit.ly/4r2X2KA

Airway mucus plugs in asthma and #COPD: pathobiology, imaging, and implications for clinical trials doi.org/10.1093/ajrccm/aamag… @atscommunity

ERJ Open Research: CPA/ABPA overlap represents a distinct clinical phenotype in individuals with CPA associated with underlying airway disease, antifungal resistance and Th2-driven inflammation, with rising biomarkers linked to disease progression bit.ly/4eR5Xwv

Breathe: Structural sequelae after TB underpin infectious PTLD: bacterial, fungal and non-TB mycobacterial. Complications are frequent yet under-diagnosed, worsening mortality and quality of life. bit.ly/4viER5M